These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33598766)

  • 1. Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus.
    Volonté MA; Clarizio G; Galantucci S; Scamarcia PG; Cardamone R; Barzaghi LR; Falautano M; Mortini P; Comi G; Filippi M
    J Neurol; 2021 Aug; 268(8):2821-2830. PubMed ID: 33598766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
    Rizzone MG; Fasano A; Daniele A; Zibetti M; Merola A; Rizzi L; Piano C; Piccininni C; Romito LM; Lopiano L; Albanese A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):376-81. PubMed ID: 24508574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
    J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson's disease.
    Genovese D; Bove F; Rigon L; Tufo T; Izzo A; Calabresi P; Bentivoglio AR; Piano C
    Neurol Sci; 2024 Feb; 45(2):565-572. PubMed ID: 37700176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.
    Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up.
    Zhang J; Jia G; Yang Z; Liu D; Hou Y; Wang Y; Yang Z
    Neurosci Lett; 2019 Jul; 705():99-105. PubMed ID: 31028845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients.
    Li J; Zhang Y; Li Y
    Br J Neurosurg; 2015 Jun; 29(3):329-33. PubMed ID: 25812021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of motor symptoms progression in Parkinson's disease patients with long-term bilateral subthalamic deep brain stimulation.
    Tagliati M; Martin C; Alterman R
    Int J Neurosci; 2010 Nov; 120(11):717-23. PubMed ID: 20942586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspnea after subthalamic deep brain stimulation in Parkinson's disease: a case-control study.
    Meoni S; Bradi AC; Wadia P; Poon YY; Moro E
    J Neurol; 2020 Oct; 267(10):3054-3060. PubMed ID: 32524258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
    Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
    Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson's Disease: The Role of Standard Screening Measures and Wearable-Data.
    Geraedts VJ; van Vugt JPP; Marinus J; Kuiper R; Middelkoop HAM; Zutt R; van der Gaag NA; Hoffmann CFE; Dorresteijn LDA; van Hilten JJ; Contarino MF
    J Parkinsons Dis; 2023; 13(4):575-588. PubMed ID: 37182900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?
    Merola A; Rizzi L; Zibetti M; Artusi CA; Montanaro E; Angrisano S; Lanotte M; Rizzone MG; Lopiano L
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):552-9. PubMed ID: 23847290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.